Cellectar Biosciences, Inc. · NASDAQ:CLRB
Bleichroeder LP reported a 6.08% stake in Cellectar Biosciences, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Bleichroeder LP reported a 6.08% stake in Cellectar Biosciences, Inc., 200,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 6.08%
- Shares
- 200,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bleichroeder LP | 6.08% | 200,000 |
| Bleichroeder Holdings LLC | 6.08% | 200,000 |
| Andrew Gundlach | 6.08% | 200,000 |
Source
Related
- Cellectar Biosciences, Inc.
- Bleichroeder LP
- Cellectar Biosciences, Inc. shareholders
- Schedule 13G · Bleichroeder LP · Aug 13, 2026
- Schedule 13G/A · Bleichroeder LP · Feb 13, 2026
- Schedule 13G · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · Silverarc Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Empery Asset Management, LP · Aug 4, 2026